(S)-crizotinib is an active pharmaceutical ingredient used in the manufacturing of anticancer medications. It functions as a tyrosine kinase inhibitor targeting c-Met/HGFR, ALK, and ROS1, primarily for research and pharmaceutical production related to non-small cell lung carcinoma.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 1374356-45-2
Tert-Butyl 4-(4-(6-aMino-5-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)pyridin-3-yl)-1H-pyrazol-1-yl)piperidine-1-carboxylate, (R)-
pharmaceutical intermediate
Ribociclib succinate
Active pharmaceutical ingredient
Rociletinib
active pharmaceutical ingredient
Trilaciclib
active pharmaceutical ingredient
NB-124 sulfate
active pharmaceutical ingredient
Crizotinib
active pharmaceutical ingredient
3-[(1S)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-ylpyrazol-4-yl)pyridin-2-amine
KTEIFNKAUNYNJU-LBPRGKRZSA-N
C[C@@H](C1=C(C=CC(=C1Cl)F)Cl)OC2=C(N=CC(=C2)C3=CN(N=C3)C4CCNCC4)N